Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimating a treatment effect with the accelerated hazards models.

Y Q Chen1, M Wang

  • 1Division of Biostatistics, School of Public Health, University of California, Berkeley, CA, USA.

Controlled Clinical Trials
|July 29, 2000
PubMed
Summary

This study introduces the accelerated hazards model as a simple alternative for analyzing time-to-event data in clinical trials. It helps understand how treatments affect the hazard progression over time, illustrated with glioma treatment data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomechanical evaluation of posterior and anterior lumbar interbody fusion techniques.

Journal of spinal disorders·1998
Same author

Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.

Transplantation proceedings·1998
Same author

Pulmonary function of nonsmoking female asbestos workers without radiographic signs of asbestosis.

Archives of environmental health·1998
Same author

Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.

Journal of cellular physiology·1998
Same author

The inhibitory effect of interleukin 1beta on rat hepatocyte DNA synthesis is mediated by nitric oxide.

Hepatology (Baltimore, Md.)·1998
Same author

[Detection of the mutant phenylalanine hydroxylase gene by dideoxy fingerprinting].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics·1998

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Clinical Trials

Background:

  • Time-to-event data analysis commonly uses proportional hazards or accelerated failure time models.
  • Identifying treatment effects in survival data is crucial for clinical decision-making.

Purpose of the Study:

  • To introduce and discuss the accelerated hazards model as a novel approach for analyzing time-to-event data.
  • To illustrate the application of the accelerated hazards model using real-world survival data from a malignant glioma clinical trial.

Main Methods:

  • The accelerated hazards model characterizes treatment effects using the hazard progression time ratio.
  • This model is suitable when treatments are hypothesized to accelerate or decelerate the underlying hazard progression.
  • Survival data from a randomized placebo-controlled trial for malignant gliomas was utilized for demonstration.

Related Experiment Videos

Main Results:

  • The accelerated hazards model provides a straightforward method for interpreting treatment effects on hazard progression.
  • The model's utility was demonstrated through its application to survival data from a malignant glioma study.

Conclusions:

  • The accelerated hazards model offers a valuable and simple alternative for analyzing time-to-event data in clinical research.
  • This approach enhances the understanding of treatment impacts on the timing and rate of events in survival analysis.